Latest
Semiquantitative perfusion analysis
Heart failure work up
Case 190: MVO and IMH Re-assessed
IMH has poorer prognosis than patients with MVO without IMH or without MVO
ICI Myocarditis
Cardiac Mass
Stress Cardiomyopathy
Case 186: Myocardial Fibroblast Activation Imaging
FAP uptake in the myocardium is always abnormal and should be reported and then worked up for ischemic or non-ischemic etiologies of fibrosis, if the patient is not a known case of cardiac disease.
VHD Series: Tricuspid Valve
VHD Series: Pulmonary valve
VHD Series: Stenotic lesions
Case 182: Double or Triple Trouble
It is important to know how to pick up subclinical rheumatic mitral valve disease and how to characterize further a bicuspid aortic valve.
VHD Series: Aortic regurgitation
VHD Series: Secondary MR
VHD Series: Mitral valve prolapse
VHD Series: Mitral Regurgitation
Valvular HD
Case 177: Fish-Mouth and Hockey-Stick
It is important to know the MRI findings of RHD and RHD MS, especially if you practice in India
RV enlargement
Infarcts
Peri-infarct ischaemia
Granulomatous Cardiomyopathy
Pulmonary sarcoidosis
Hypertrophic Cardiomyopathy
Case 173: Microvascular Dysfunction in Hypertrophic Cardiomyopathy
Adenosine stress CMR can diagnosis microvascular ischemia/dysfunction in patients with hypertrophic cardiomyopathy
Cardiomyopathy
NDLVC: Approach
Myocarditis
Eosonophilic myocarditis
This case describes myocardial and lung changes related to persistent high eosonophil counts. Clinical picture along with lab findings and imaging features confirm the diagnosis. Cardiac involvement is associated with high morbidity and mortality, hence it is important to diagnose these cases early and appropriate manage them.
Myocardial Calcification
Case 170: Heart of Stone
Calcification in different parts of the heart can help with diagnosis and prognostication
Infarcts
Classification of AMI
Non-Ischemic Cardiomyopathy
Cardiac Sarcoid
Tumors
Mass or pseudomass?
Tumors
Cardiac mass
Getting Started
Step wise reading of CMR
Ischaemic HD
Snippet 164: Why CMR is Better than FDG-PET for Viability Assessment
CMR brings so much more to the table in the setting of infarct and viability imaging as compared to FDG-PET
LGE
Heart Transplant rejection: CMR
Infarcts